fda semaglutide weight loss The has approved the first GLP-1 pill for loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular A big win for Wegovy:

Reduced appetite and decreased calorie intake with semaglutide can lead to significant weight reduction

How it works get your Semaglutide prescription in 4 steps Fill the online medical questionnaire (23 minutes)

On procedures, the FDA found that Novo Nordisk's internal protocol allowed adverse drug experiences to be rejected if the reporter believed events were unrelated to the drug directly contradicting FDA regulations requiring all serious and unexpected events to be reported regardless of suspected causality

The active product and corresponding placebo product were visually identical to maintain masking of participants and site staff